SIG
AZN icon

Senator Investment Group’s AstraZeneca AZN Stock Holding History

Senator Investment Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-750,000
Closed -$99.5M – 58
2022
Q1 		$99.5M Sell
750,000
-125,000
-14% -$15M 3.09% 9
2021
Q4 		$102M Buy
875,000
+125,000
+17% +$14.7M 1.97% 17
2021
Q3 		$90.1M Buy
750,000
+250,000
+50% +$29.1M 1.54% 18
2021
Q2 		$59.9M Hold
500,000
– – 1.14% 36
2021
Q1 		$49.7M Buy
500,000
+450,000
+900% +$45.2M 1.02% 37
2020
Q4 		$5M Buy
+50,000
New +$5.3M 0.09% 91

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Senator Investment Group's AZN Position: Q2 2022 in Review

Senator Investment Group sold out of AstraZeneca (AZN) in Q2 2022, closing a stake of 750,000 shares — an estimated $99.5M sold.

Senator Investment Group first reported a position in AZN in Q4 2020 and held it in 6 quarters. The position peaked at $102M in Q4 2021. 1,015 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

  • Senator Investment Group reported no remaining AstraZeneca position as of Q2 2022 after selling out during the quarter.
  • Senator Investment Group sold 750,000 AstraZeneca shares in Q2 2022, an estimated $99.5M.
  • Senator Investment Group first reported a position in AstraZeneca in Q4 2020 and held it in 6 quarters.
  • Senator Investment Group's AstraZeneca position peaked at $102M in Q4 2021.
  • 1,015 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Senator Investment Group's 13F filing for Q2 2022, filed 15 Aug 2022.